Dr Chris Tromans

Volpara Solutions

Chris is the European Business and Innovation Manager for Volpara Solutions leading the company’s scientific validation and clinical adoption pathway in Europe. He oversees the company’s research projects in a number of European countries, including the NIHR PROCAS II programme grant, lead from Manchester Foundation Trust. This is a proof of concept study using state of the art Cloud technologies to build a practical implementation of cancer risk assessment in screening within the NHS Breast Screening Programme. The ultimate goal being to use risk to personalising care.
He is a graduate of Oxford University, where he also completed his PhD in medical image analysis under the supervision of Professor Sir Michael Brady. Following his PhD, he won a research fellowship award from the EPSRC to independently continue his work on mammographic image quantification, before joining Volpara in 2012 to focus on commercialisation of research into clinical practise.

dont miss

Optimising and Personalising Breast Screening using Analytics and Cancer Risk

Breast screening requires reading vast numbers of images, where only a small proportion contain the subtlest signs of cancer. This talk begins discussing how analytics tools can ensure only images of the highest quality reach the reading room, maximising the radiologist’s ability to identify lesions. We then turn to those breasts where dense tissue limits mammographic sensitivity, or those at high risk, and how to personalise screening to counteract this.

EVEN MORE SEMINARS

  • Emily Smith: Speaking at the Medical Imaging Convention

    Emily Smith
    United Lincolnshire Hospitals NHS Trust

    Task-based image quality assessment for CT optimisation

  • Dr Raj Jena: Speaking at the Medical Imaging Convention

    Dr Raj Jena
    Microsoft Research Cambridge & University of Cambridge Department of Oncology

    Building AI workflows for segmentation and analysis of medical imaging

  • Louise Tromans: Speaking at the Medical Imaging Convention

    Louise Tromans
    Sandwell & West Birmingham Hospitals NHS Trust

    Tomosynthesis in Breast Screening Assessment

  • Professor Stuart Taylor: Speaking at the Medical Imaging Convention

    Professor Stuart Taylor
    University College London

    Should we be using first line whole body MRI in colorectal and lung cancer staging?

  • Dr Anna Barnes: Speaking at the Medical Imaging Convention

    Dr Anna Barnes
    University College Hospital

    Imaging biomarkers to investigate neuropathology